SM
MDGSW

Sabby Management’s Medigus Ltd. Series C Warrant MDGSW Stock Holding History

Sabby Management’s Portfolio MDGSW Stock Details MDGSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-544,940
Closed -$93K – 160
2020
Q3 		$93K Sell
544,940
-40,919
-7% -$8.44K 0.01% 117
2020
Q2 		$123K Sell
585,859
-421,585
-42% -$145K 0.02% 81
2020
Q1 		$22K Sell
1,007,444
-1,000
-0.1% -$359 0.01% 80
2019
Q4 		$93K Hold
1,008,444
– – 0.03% 62
2019
Q3 		$101K Sell
1,008,444
-22,210
-2% -$10.7K 0.05% 75
2019
Q2 		$218K Buy
1,030,654
+16,067
+2% +$7.76K 0.27% 54
2019
Q1 		$457K Sell
1,014,587
-29,177
-3% -$17.1K 0.22% 36
2018
Q4 		$522K Sell
1,043,764
-224,382
-18% -$153K 0.11% 49
2018
Q3 		$926K Buy
+1,268,146
New +$754K 0.12% 56

Other funds holding MDGSW

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return

Sabby Management's MDGSW Position: Q4 2020 in Review

Sabby Management sold out of Medigus Ltd. Series C Warrant (MDGSW) in Q4 2020, closing a stake of 544,940 shares — an estimated $93K sold.

Sabby Management first reported a position in MDGSW in Q3 2018 and held it in 9 quarters. The position peaked at $926K in Q3 2018. 6 funds tracked by Wall St. Rank hold MDGSW as of Q4 2020.

  • Sabby Management reported no remaining Medigus Ltd. Series C Warrant position as of Q4 2020 after selling out during the quarter.
  • Sabby Management sold 544,940 Medigus Ltd. Series C Warrant shares in Q4 2020, an estimated $93K.
  • Sabby Management first reported a position in Medigus Ltd. Series C Warrant in Q3 2018 and held it in 9 quarters.
  • Sabby Management's Medigus Ltd. Series C Warrant position peaked at $926K in Q3 2018.
  • 6 funds tracked by Wall St. Rank held Medigus Ltd. Series C Warrant as of Q4 2020.

Based on Sabby Management's 13F filing for Q4 2020, filed 16 Feb 2021.